NewsMeter

Weight-loss drugs for overweight cats put pet-food giants on notice

7/19/2026

GLP-1 treatments are entering veterinary medicine. Startups are testing the weight-loss drugs on overweight cats, targeting a moment when pet owners are spending more on animal health.

Pet-food giants are already repositioning, leaning into longevity products. Startups bring GLP-1 into feline trials The patient is the overweight cat.

Startups are leading the work, not established pharmaceutical companies. Trial data and commercial timelines are not yet public.

Spending on animal health is rising, and startups testing GLP-1 in cats are pricing that trend into their bets. The drug mechanism targets weight.